Why the study?
Correction of iron deficiency with intravenous iron in HF patients may improve outcomes but is rarely assessed in real-world studies, and hospital admission presents an opportunity for identification and treatment.
What is the frequency and what are the predictors of iron deficiency screening in patients admitted with acute decompensated heart failure?
Population
2,275 patient admissions for decompensated HF
Design
Observational study
Key result
Assessment of iron status was performed in only 23.1% of 2,275 patients admitted for acute decompensated heart failure, with testing primarily driven by anemia rather than heart failure guidelines.
Authors
Loading...
Infrequent iron study availability during decompensated HF admissions highlights a care gap; leaves open whether routine testing improves outcomes.
Observational (n=2,275)
No
What is the frequency and what are the predictors of iron deficiency screening in patients admitted with acute decompensated heart failure?
Despite guidelines, iron deficiency screening in acute heart failure remains low and is primarily driven by anemia rather than heart failure status.
Sindledecker et al. (2026) conducted an observational in Acute decompensated heart failure (n=2,275). Iron status assessment (ferritin and TSAT) was evaluated on Availability of iron studies within 180 days prior to or during admission. Assessment of iron status was performed in only 23.1% of 2,275 patients admitted for acute decompensated heart failure, with testing primarily driven by anemia rather than heart failure guidelines.